{
  "docId": "019de073-9e32-71bd-acba-301a2d9cbf00",
  "docSlug": "d469b8223f6f86cb5d6a1f0a99cbce5c",
  "documentTitle": "Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 28,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-9e32-71bd-acba-301a2d9cbf00/4",
  "deckHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00",
  "deckJsonHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00.json",
  "deckAnchorHref": "/decks/019de073-9e32-71bd-acba-301a2d9cbf00#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.88,
        "x": 0.06,
        "y": 0.435
      },
      "kind": "list",
      "text": "Delivering Groundbreaking Medicines: Focused on disease modifying therapies, Strong engagement with patient communities, Efficient clinical development and commercialization model",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "14c0e647-5f02-4100-bbda-bdd162a88468",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.88,
        "x": 0.06,
        "y": 0.675
      },
      "kind": "list",
      "text": "Redefining the Possible: Novel approach to unconventional targets, High unmet need and limited competition drive significant commercial opportunity",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64ac22be-678a-48b3-92d6-a127907b6e10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.88,
        "x": 0.06,
        "y": 0.19
      },
      "kind": "list",
      "text": "Pioneering Bold Science: Innovative enzyme engineering platform, Differentiated product profiles, Expertise in metabolic disease and enzyme engineering creates complementary opportunities in areas with limited competition",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2cfb3e3-635c-4cda-8e8e-443268c4865b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.8,
        "x": 0.06,
        "y": 0.05
      },
      "kind": "title",
      "text": "Building an Enzyme Therapy Company to Serve Patients and Drive Near and Long-Term Growth",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb964f46-14b3-4ff7-9d57-59e1ad1ce6d9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "25604a0d-0753-4fa6-a481-0d94feaa8104",
      "evidence": "Building an Enzyme Therapy Company to Serve Patients and Drive Near and Long-Term Growth",
      "confidence": 0.8
    },
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "e28866a0-08eb-4b93-ac27-ac2c19ce776b",
      "evidence": "list/bullet: Pioneering Bold Science",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}